rufinamide has been researched along with Epilepsy, Absence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albini, M; Casciato, S; Di Bonaventura, C; Fanella, M; Fattouch, J; Giallonardo, AT; Lapenta, L; Manfredi, M; Morano, A | 1 |
| Benedict, A; Maclaine, G; Verdian, L | 1 |
| Arroyo, S; Glauser, T; Kluger, G; Krauss, G; Perdomo, C; Sachdeo, R | 1 |
1 review(s) available for rufinamide and Epilepsy, Absence
| Article | Year |
|---|---|
Effectiveness of Rufinamide in the Treatment of Idiopathic Generalized Epilepsy With Atypical Evolution: Case Report and Review of the Literature.
Topics: Adult; Anticonvulsants; Disease Progression; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Humans; Treatment Outcome; Triazoles | 2016 |
1 trial(s) available for rufinamide and Epilepsy, Absence
| Article | Year |
|---|---|
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Epilepsy; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Humans; Male; Syndrome; Treatment Outcome; Triazoles | 2008 |
1 other study(ies) available for rufinamide and Epilepsy, Absence
| Article | Year |
|---|---|
The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Computer Simulation; Cost-Benefit Analysis; Epilepsy, Absence; Fructose; Health Care Costs; Humans; Infant; Intellectual Disability; Lamotrigine; Models, Economic; Randomized Controlled Trials as Topic; Syndrome; Time Factors; Topiramate; Treatment Outcome; Triazines; Triazoles; United Kingdom | 2010 |